Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Organogenesis Holdings (ORGO) Interest & Investment Income (2017 - 2019)

Organogenesis Holdings has reported Interest & Investment Income over the past 3 years, most recently at $19000.0 for Q1 2019.

  • For Q1 2019, Interest & Investment Income changed 0.0% year-over-year to $19000.0; the TTM value through Mar 2019 reached $64000.0, down 41.82%, while the annual FY2018 figure was $64000.0, 50.39% down from the prior year.
  • Interest & Investment Income for Q1 2019 was $19000.0 at Organogenesis Holdings, up from $5000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $38000.0 in Q1 2017 and troughed at $5000.0 in Q4 2018.
  • A 3-year average of $23555.6 and a median of $20000.0 in 2018 define the central range for Interest & Investment Income.
  • Biggest five-year swings in Interest & Investment Income: crashed 82.14% in 2018 and later changed 0.0% in 2019.
  • Year by year, Interest & Investment Income stood at $28000.0 in 2017, then crashed by 82.14% to $5000.0 in 2018, then surged by 280.0% to $19000.0 in 2019.
  • Business Quant data shows Interest & Investment Income for ORGO at $19000.0 in Q1 2019, $5000.0 in Q4 2018, and $20000.0 in Q3 2018.